綠城中國(03900.HK)擬向中交舟山公司提供項目管理服務
格隆匯3月25日丨綠城中國(03900.HK)發佈公告,2020年3月25日,公司全資附屬公司綠城管理與中交舟山公司(由於為公司的主要股東中交集團的非全資附屬公司而成為公司的關連人士)訂立協議。根據該協議,綠城管理同意為中交舟山公司就該項目提供項目管理服務,代價為該項目總造價的3%(於該公告日期為人民幣5400萬元)。
該項目為舟山自貿金融中心項目,位於浙江舟山千島中央商務區,總建設用地面積約為29,219.43平方米,將開發為酒店、商用物業、商業辦公室及公用設施;於該公告日期,估計項目總施工成本為人民幣18億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.